{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T17:54:43Z","timestamp":1764784483168,"version":"build-2065373602"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,10,9]],"date-time":"2020-10-09T00:00:00Z","timestamp":1602201600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"Lysosomal Storage Diseases","award":["14682"],"award-info":[{"award-number":["14682"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Genetics and Metabolism Reports"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1016\/j.ymgmr.2020.100663","type":"journal-article","created":{"date-parts":[[2020,10,21]],"date-time":"2020-10-21T05:17:57Z","timestamp":1603257477000},"page":"100663","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Diffuse large B-cell non-Hodgkin's lymphoma in Gaucher disease"],"prefix":"10.1016","volume":"25","author":[{"given":"Grant","family":"Bonesteele","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. Jay","family":"Gargus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emily","family":"Curtin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mabel","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barry","family":"Rosenbloom","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Virginia","family":"Kimonis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"year":"2020","series-title":"Online Mendelian Inheritance in Man, OMIM\u00ae","key":"10.1016\/j.ymgmr.2020.100663_bb0005"},{"key":"10.1016\/j.ymgmr.2020.100663_bb0010","first-page":"499","article-title":"Gaucher disease types 1, 2, and 3: differential mutations of the acid beta-glucosidase active site identified with conduritol B epoxide derivatives and sphingosine","volume":"37","author":"Grabowski","year":"1985","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.ymgmr.2020.100663_bb0015","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/0006-291X(65)90743-6","article-title":"Metabolism of glucocerebrosides II. Evidence of an enzymatic deficiency in Gaucher\u2019s disease","volume":"18","author":"Brady","year":"1965","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ymgmr.2020.100663_bb0020","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1111\/j.1365-2141.2004.05351.x","article-title":"Gaucher disease: pathological mechanisms and modern management","volume":"129","author":"Jmoudiak","year":"2005","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.ymgmr.2020.100663_bb0025","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1016\/S0140-6736(08)61522-6","article-title":"Phenotype, diagnosis, and treatment of Gaucher\u2019s disease","volume":"372","author":"Grabowski","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.ymgmr.2020.100663_bb0030","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1002\/humu.20676","article-title":"Gaucher disease: mutation and polymorphism spectrum in the glucocerebrosidase gene (GBA)","volume":"29","author":"Hruska","year":"2008","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.ymgmr.2020.100663_bb0035","series-title":"The Cochrane Collaboration (Ed.), Cochrane Database of Systematic Reviews","first-page":"CD010324","article-title":"Enzyme replacement and substrate reduction therapy for Gaucher disease","author":"Shemesh","year":"2013"},{"key":"10.1016\/j.ymgmr.2020.100663_bb0040","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1056\/NEJM199105233242104","article-title":"Replacement therapy for inherited enzyme deficiency \u2014 macrophage-targeted Glucocerebrosidase for Gaucher\u2019s disease","volume":"324","author":"Barton","year":"1991","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ymgmr.2020.100663_bb0045","doi-asserted-by":"crossref","first-page":"2835","DOI":"10.1001\/archinte.160.18.2835","article-title":"The Gaucher registry: demographics and disease characteristics of 1698 patients with Gaucher disease","volume":"160","author":"Charrow","year":"2000","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.ymgmr.2020.100663_bb0050","first-page":"855","article-title":"High frequency of the Gaucher disease mutation at nucleotide 1226 among Ashkenazi Jews","volume":"49","author":"Zimran","year":"1991","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.ymgmr.2020.100663_bb0055","doi-asserted-by":"crossref","first-page":"S25","DOI":"10.1002\/ajh.24057","article-title":"Gaucher disease and comorbidities: B-cell malignancy and parkinsonism: Gaucher disease and its comorbidities","volume":"90","author":"Cox","year":"2015","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.ymgmr.2020.100663_bb0060","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1007\/s10354-010-0850-x","article-title":"Neuropathic Gaucher disease","volume":"160","author":"Pastores","year":"2010","journal-title":"Wien. Med. Wochenschr."},{"key":"10.1016\/j.ymgmr.2020.100663_bb0065","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1111\/bjh.12335","article-title":"Malignancies and monoclonal gammopathy in Gaucher disease; a systematic review of the literature","volume":"161","author":"Arends","year":"2013","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.ymgmr.2020.100663_bb0070","doi-asserted-by":"crossref","first-page":"4569","DOI":"10.1182\/blood-2004-12-4672","article-title":"Gaucher disease and cancer incidence: a study from the Gaucher registry","volume":"105","author":"Rosenbloom","year":"2005","journal-title":"Blood."},{"key":"10.1016\/j.ymgmr.2020.100663_bb0075","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1002\/ajh.21362","article-title":"The underrecognized progressive nature of N370S Gaucher disease and assessment of cancer risk in 403 patients","volume":"84","author":"Taddei","year":"2009","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.ymgmr.2020.100663_bb0080","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1182\/blood-2014-12-617514","article-title":"NKT-dependent B-cell activation in Gaucher disease","volume":"125","author":"Salio","year":"2015","journal-title":"Blood."},{"key":"10.1016\/j.ymgmr.2020.100663_bb0085","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1182\/blood-2014-09-600270","article-title":"Type II NKT-TFH cells against Gaucher lipids regulate B-cell immunity and inflammation","volume":"125","author":"Nair","year":"2015","journal-title":"Blood."},{"key":"10.1016\/j.ymgmr.2020.100663_bb0090","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1002\/pd.2584","article-title":"Sixteen years of prenatal consultations for the N370S\/N370S Gaucher disease genotype: what have we learned?: prenatal consultations for Gaucher disease","volume":"30","author":"Eitan","year":"2010","journal-title":"Prenat. Diagn."},{"key":"10.1016\/j.ymgmr.2020.100663_bb0095","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.bcmd.2010.10.006","article-title":"The incidence of parkinsonism in patients with type 1 Gaucher disease: data from the ICGG Gaucher registry","volume":"46","author":"Rosenbloom","year":"2011","journal-title":"Blood Cell Mol. Dis."},{"key":"10.1016\/j.ymgmr.2020.100663_bb0100","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.bcmd.2005.03.004","article-title":"Incidence of malignancies among patients with type I Gaucher disease from a single referral clinic","volume":"34","author":"Zimran","year":"2005","journal-title":"Blood Cell Mol. Dis."},{"key":"10.1016\/j.ymgmr.2020.100663_bb0105","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.bcmd.2005.08.004","article-title":"Increased incidence of cancer in adult Gaucher disease in Western Europe","volume":"36","author":"de Fost","year":"2006","journal-title":"Blood Cell Mol. Dis."},{"key":"10.1016\/j.ymgmr.2020.100663_bb0110","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1001\/archinte.167.11.1189","article-title":"Risk of malignant disease among 1525 adult male US veterans with Gaucher disease","volume":"167","author":"Landgren","year":"2007","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.ymgmr.2020.100663_bb0115","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1001\/archinternmed.2007.128","article-title":"Prevalence of type 1 Gaucher disease in the United States","volume":"168","author":"Weinreb","year":"2008","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.ymgmr.2020.100663_bb0120","doi-asserted-by":"crossref","first-page":"3799","DOI":"10.1182\/blood.V104.11.3799.3799","article-title":"Changing patterns of mortality in Gaucher disease prior to and following the advent of enzyme replacement therapy","volume":"104","author":"Weinreb","year":"2004","journal-title":"Blood."},{"key":"10.1016\/j.ymgmr.2020.100663_bb0125","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1615\/CritRevOncog.2013005921","article-title":"Causes of death due to hematological and non-hematological cancers in 57 US patients with type 1 Gaucher disease who were never treated with enzyme replacement therapy","volume":"18","author":"Weinreb","year":"2013","journal-title":"Crit. Rev. Oncog."},{"year":"2020","series-title":"Hematologic Malignancies and Gammopathis in Gaucher Disease Type 1","author":"Cappellini","key":"10.1016\/j.ymgmr.2020.100663_bb0130"},{"key":"10.1016\/j.ymgmr.2020.100663_bb0135","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1615\/CritRevOncog.2013004503","article-title":"Immunological cells and functions in Gaucher disease","volume":"18","author":"Pandey","year":"2013","journal-title":"Crit. Rev. Oncog."},{"key":"10.1016\/j.ymgmr.2020.100663_bb0140","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1038\/nature21368","article-title":"Complement drives glucosylceramide accumulation and tissue inflammation in Gaucher disease","volume":"543","author":"Pandey","year":"2017","journal-title":"Nature."},{"key":"10.1016\/j.ymgmr.2020.100663_bb0145","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1615\/CritRevOncog.2013006145","article-title":"Gaucher disease and malignancy: a model for cancer pathogenesis in an inborn error of metabolism","volume":"18","author":"Mistry","year":"2013","journal-title":"Crit. Rev. Oncog."}],"container-title":["Molecular Genetics and Metabolism Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2214426920301099?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2214426920301099?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T12:50:55Z","timestamp":1762001455000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2214426920301099"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":29,"alternative-id":["S2214426920301099"],"URL":"https:\/\/doi.org\/10.1016\/j.ymgmr.2020.100663","relation":{},"ISSN":["2214-4269"],"issn-type":[{"type":"print","value":"2214-4269"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Diffuse large B-cell non-Hodgkin's lymphoma in Gaucher disease","name":"articletitle","label":"Article Title"},{"value":"Molecular Genetics and Metabolism Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymgmr.2020.100663","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"100663"}}